Date: 2026-04-06 Quarter: Q4 FY2025 (Dec 2025) — First public earnings (IPO Jan 28, 2026) Market cap: ~$0.75B | EV/TTM Rev: ~1.1x | Revenue growth: +65.5% YoY (Q4), +52.1% YoY (FY)
Ethos is a rare find: a profitable, 50%+ growth company trading at 1.1x EV/revenue and ~10x GAAP earnings because the stock has been crushed post-IPO (down 37% from $19 to $11.89). The business fundamentals are exceptional — 98% gross margins, 22% GAAP operating margins, Rule of 40 at 88, and a three-sided platform with real network effects in the fragmented $140B+ life insurance market. The lockup overhang (July 2026) and SoftBank's underwater position are creating a dislocation. This is the cheapest high-quality growth company I have seen in the current market. Conviction: 4/5 — would be 5 if not for carrier concentration risk, limited public track record (1 quarter), and the lockup cliff.
| Criterion | Threshold | Actual | Verdict |
|---|---|---|---|
| Revenue YoY growth | >30% (>40% preferred) | +65.5% Q4, +52.1% FY | PASS |
| Gross margin | >60% (>70% preferred) | 98.1% | PASS |
| Revenue per quarter | >$50M | $110.1M | PASS |
| Data availability | 4+ quarters | 5 quarters | PASS |
| Share dilution | <10% annual | ~8.6% (IPO-driven, one-time) | PASS |
| GAAP profitability | Improving or positive | Net income $71.2M FY25, +46% YoY | PASS |
All gates passed. Notably, LIFE passes every threshold at the preferred level, not just the minimum.
| Factor | Rating | Detail |
|---|---|---|
| Growth | Strong | +65.5% YoY Q4, +52.1% FY. Third consecutive year >50%. Q1'26 guide +53-63% YoY. |
| Trajectory | Mixed | Volatile intra-year: +66→+58→+34→+53→+65. Re-accelerated H2 but FY26 guide implies deceleration to +32%. Likely conservative first-year guide. |
| Margins | Exceptional | 98% gross (asset-light, no insurance risk). 22% GAAP op margin. 23% Adj EBITDA. Contribution margin expanding to 43%. |
| Dominance | Strong | #1 digital life insurance platform. Haven Life exited market. Ladder is term-only, max age 60. #1 source of premiums for 3 of 6 carriers. NPS 70 vs industry 14. Carriers using Ethos grow 2x+ faster (LIMRA). |
| Valuation | Cheap | EV/TTM Rev 1.1x. P/E ~10.5x TTM. P/S 1.9x. Growing 52% with 22% net margins. Absurdly cheap for the growth + profitability profile. |
| Special | Present | Post-IPO lockup overhang (July 2026) depressing price. SoftBank invested at 2.7Bvaluationin2021, nowat 0.75B. Potential for violent re-rating once lockup passes and coverage expands. 9 analysts at Strong Buy, avg target $20.25 (70% upside). |
| | Q424 | Q125 | Q225 | Q325 | Q425 | | | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | |---|---|---|---|---|---| | Revenue ($M) | 66.5 | ~89.0 | ~94.0 | ~95.0 | **110.1** | | YoY % | +66% | +58% | +34% | +53% | **+65.5%** | | QoQ % | — | +33.8% | +5.6% | +1.1% | **+15.9%** | | Gross Margin % [GAAP] | 97.7% | ~98% | ~98% | ~98% | **98.1%** | | Op Margin % [GAAP] | 18.8% | — | — | — | **22.2%** | | Net Margin % [GAAP] | 14.3% | — | — | — | **22.3%** | | Adj EBITDA ($M) | ~15 | ~19 | ~21 | ~24 | 25.8 | | EBITDA Margin % | ~22% | ~21% | ~22% | ~25% | 23% | | EPS (diluted) | 0.16| 0.24 | ~0.24| 0.31 | **0.42 * *||PoliciesActivated|38, 515|46, 283|49, 219|48, 122|* * 54, 714 * *||ARPU() | 1,727 | 1,920 | 1,906 | 1,972 | 2,012 | | Contribution Margin % | 39.1% | 41.6% | 40.4% | 42.1% | 42.9% |
Q1-Q3 FY25 revenue/EBITDA approximate from investor presentation charts. Full P&L detail only available for Q4 FY24 and Q4 FY25 (pre-IPO company).
Annual:
| Year | Revenue ($M) | YoY % | Adj EBITDA ($M) | EBITDA Margin | Net Income ($M) | Net Margin |
|---|---|---|---|---|---|---|
| FY2023 | 159.8 | — | ~7 | ~4% | — | — |
| FY2024 | 254.9 | +59.6% | 58.0 | 22.8% | 48.8 | 19.2% |
| FY2025 | 387.6 | +52.1% | 89.0 | 23.0% | 71.2 | 18.4% |
First Atlas analysis — no prior beliefs to update. Using Thesis/Anti-Thesis framework for initial coverage.
Ethos is the dominant digital distribution platform for life insurance in the US, operating as a three-sided marketplace (consumers / agents / carriers) with network effects. The company earns commission revenue (98% gross margin) with zero balance sheet risk — carriers hold 100% of insurance risk. It is profitable on a GAAP basis, generating $71M net income on $388M revenue. Growth is sustained at 50%+ annually for three consecutive years. The $12.6B addressable market (existing products) is <4% penetrated, with a $140B+ TAM if annuities and supplemental health are included. At 1.1x EV/revenue and ~10x P/E for a 50%+ grower, the stock is mispriced due to post-IPO technicals (lockup, SoftBank overhang, thin float).
Limited leading indicator data for a recently public insurance distribution company. No RPO, ARR, billings, or NRR metrics apply to this business model.
Available signals:
| Indicator | Q424-Q125 | Q125-Q225 | Q225-Q325 | Q325-Q425 | Signal |
|---|---|---|---|---|---|
| Policies Activated QoQ | +20.2% | +6.3% | -2.2% | +13.7% | Mixed. Q3 dip recovered in Q4 but volatile. |
| ARPU ($) QoQ | +11.2% | -0.7% | +3.5% | +2.0% | Bullish. Steadily expanding, now $2,012. Higher-value products driving mix. |
| Direct Revenue QoQ | +31.6% | +12.0% | +10.7% | +19.7% | Bullish. Accelerating sequential growth. |
| 3P Revenue QoQ | +17.9% | +15.2% | 0.0% | -5.5% | Bearish. Decelerating and now declining. |
| Contribution Margin | 41.6% | 40.4% | 42.1% | 42.9% | Bullish. Steadily expanding unit economics. |
Divergence assessment: Direct channel is accelerating (+93% YoY in Q4, +20% QoQ) while third-party is weakening. This divergence has been building for 3 quarters. If it persists, it signals that the agent platform is working but carrier partnerships may be hitting a ceiling. The direct channel carries higher S&M costs but gives Ethos more control. Net effect: revenue growth sustainable through direct channel alone, but at the cost of margin compression (more S&M required).
The expanding ARPU ($1,727 to $2,012 in 5 quarters, +16.5%) signals successful product expansion. New products (IUL, cancer insurance) are moving revenue per policy higher, which is a structural positive.
Customer sentiment — Positive. Trustpilot 4.8/5. BBB A+. Google 4.7/5. NPS 70 vs industry avg 14. Customers praise speed (95% instant decisions). Post-purchase support weaker: no live chat, slow email, buried contact info. Limited customization (no riders, no carrier choice). Sources: Trustpilot, NerdWallet, U.S. News.
Competitive landscape — Favorable. Haven Life (MassMutual) exited the market in 2026. Ladder is term-only with max issue age 60. No tech-native platform has Ethos's scale (500K+ policies, 15K agents, 6 carriers). Legacy carriers are 100+ years old with 4-8 week processes. Source: TechBuzz, U.S. News.
Employee sentiment — Mixed. Glassdoor 4.3/5, 84% recommend, 87% positive business outlook. Negative reviews flag autocratic C-suite, shifting role definitions, toxic culture in tech/product teams. Compensation rated 4.3/5. Source: Glassdoor.
Analyst views — Bullish. 9 analysts: Strong Buy consensus. Avg target $20.25 (70% upside). JPMorgan initiated Overweight. SA: "surprisingly soft debut" but fundamentals strong. Source: SA, Investing.com.
IPO context. Priced $19, day-1 close $16.85 (-11%), current $11.89 (-37%). SoftBank invested at $2.7B in 2021, now $0.75B mkt cap (72% underwater). Lockup expiry ~July 28, 2026. Source: TechCrunch, Yahoo Finance.
Price: 11.89(Apr2, 2026).Shares : 62.9M.Marketcap: 748M. Post-IPO net cash est. ~318M.EVest. 430M.
| Metric | Current | At IPO ($19) | Assessment |
|---|---|---|---|
| EV/TTM Revenue | 1.1x | 1.9x | Extremely cheap. A 52% grower at 1.1x is mispriced. |
| P/S (TTM) | 1.9x | 3.1x | Cheap even at IPO price. |
| P/E (TTM, GAAP) | 10.5x | 16.8x | Growing 52% at 10.5x earnings. PEG = 0.20. |
| P/E (Q4 annualized) | 7.6x | 12.2x | If Q4 margins sustain, even cheaper. |
| EV/Adj EBITDA (TTM) | 4.8x | 8.2x | Sub-5x EBITDA for 50%+ growth is absurd. |
| EV/NTM Revenue (FY26 guide $512M) | 0.84x | 1.5x | Below 1x EV/NTM revenue. |
| Rule of 40 | 88 | 88 | Top-decile for any growth company. |
Peer context: No direct public peers. ROOT (auto insurtech) at 3-4x rev, lower growth/margins. LMND at 5-6x rev, negative profitability. Generic 50%+ growth SaaS trades at 10-20x revenue. LIFE's valuation is a pure technical dislocation.
Platform assessment: True three-sided platform with compounding network effects.
Ethos captures three of four insurance value chain layers (distribution, underwriting, administration) while pushing 100% of balance sheet risk to carriers. Asset-light, regulatory-light model.
Network effects are measurable: more consumers generate more data, which improves underwriting algorithms, enabling better pricing for carriers, attracting more carriers, which expands products, drawing more agents, which drives more consumers. 250K data points per application. 40K+ rules per decision. 1M+ proprietary rules library. This data moat compounds with every policy.
Secular tailwinds: (1) Digitization of insurance — legacy process is 4-8 weeks; Ethos is 10 minutes. (2) Life events as demand drivers — 10M Americans purchase new policies annually (births, homes, college, retirement). Non-cyclical. (3) Product expansion — from $12.6B to $140B+ TAM with annuities.
TAM penetration: $388M / $12.6B = 3.1% of existing product TAM. 0.28% of expanded TAM. Very early innings.
Carrier concentration. Top 3 carriers likely 88-98% of revenue. Single carrier departure could impair revenue 30-40%. Carriers can squeeze commission rates. Mitigation: Ethos is #1 premium source for 3 carriers — switching costs are mutual.
Lockup expiry (July 2026). SoftBank 72% underwater. Sequoia, Accel, GV also hold large positions. Selling pressure could push stock to new lows.
FY2026 guidance deceleration. +32% YoY guide vs +52% FY25. Implied Q2-Q4 average of $122M/Q after $145M Q1 suggests flat sequential revenue. Could reflect real demand softening or conservative first-year guide.
Third-party channel decline. -5.5% QoQ in Q4 after flat Q3. If carrier partnerships are pulling back, platform thesis weakens.
One public quarter. No guidance beat history. No earnings call transcript available. Cannot assess management credibility or communication quality.
Q1 FY2026 earnings (May 6, 2026). First guidance beat/miss opportunity. Revenue guide $144-146M. If they beat, re-rating is likely — first-year guides tend conservative.
Lockup expiry resolution (late July 2026). Pre-lockup fear often worse than actual event. Once selling pressure clears, overhang lifts.
New product launches. VUL, Participating Whole Life, Annuities, Supplemental Health on roadmap. Each expands TAM and ARPU.
Carrier expansion beyond 6. More carriers = more products, reduced concentration risk. Management signalled post-IPO carrier expansion (S&P Global).
Index inclusion / broader coverage. Only 9 analysts. As stock seasons, more coverage and institutional buying could drive re-rating.
No prior Atlas analysis exists for LIFE. This is initial coverage.